Patent · US Active

Synthesis methods for upadacitinib and intermediate thereof

US11926633B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 26, 2019
Grant dateMar 12, 2024
Priority date
Expiry dateMar 7, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a JAK inhibitor upadacitinib intermediate and a preparation method therefor, and to a preparation method for a JAK inhibitor upadacitinib. The upadacitinib intermediate of the present application is as shown in Formula (II) or Formula (III),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.